Product Information
LITHOBID ER 300 MG TABLET is a brand product labeled by ANI Pharmaceuticals, Inc., priced at $11.8265 per EA under NDC 62559028001. Its NADAC has been published 245 times since Jul 23, 2014.
The High Outlier badge above means this manufacturer's average price in the lithium carbonate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559028001
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LITHIUM CARBONATEApproval Type
New Drug (NDA)
FDA Application
NDA018027On Market Since
7/1/2014
Pharmacological Classes
Price Statistics
The NADAC for LITHOBID ER 300 MG TABLET has been published 245 times since Jul 23, 2014, and over the history we have for it it has risen 307.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.8265 per EA |
|---|---|
| All-time high | $12.2055 (Jun 12, 2024) |
| All-time low | $2.9000 (Jul 23, 2014) |
| 52-week high | $12.1317 |
| 52-week low | $11.8265 |
| Median price | $7.0685 |
| Average price | $8.6292 |
| Largest weekly change | +67.6% (Apr 17, 2024) |
| Weeks tracked | 245 |
| Tracking since | Jul 23, 2014 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LITHOBID ER 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LITHOBID ER 300 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $11.8265 per EA (NDC 62559028001), effective Jun 24, 2026.
How has the price of LITHOBID ER 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for LITHOBID ER 300 MG TABLET has risen 307.8%. It has been tracked across 245 weekly CMS publications since Jul 23, 2014.
What are the highest and lowest recorded NADAC prices for LITHOBID ER 300 MG TABLET?
Since Jul 23, 2014, the NADAC for LITHOBID ER 300 MG TABLET has ranged from a low of $2.9000 (Jul 23, 2014) to a high of $12.2055 (Jun 12, 2024), with a median of $7.0685 per EA.
Are there cheaper alternatives to LITHOBID ER 300 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, LITHIUM CARBONATE 300 MG CAP, is $0.0959 per EA — about 99% below LITHOBID ER 300 MG TABLET.
Who manufactures LITHOBID ER 300 MG TABLET?
LITHOBID ER 300 MG TABLET (NDC 62559028001) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification